Paris-based Sofinnova Partners, a leading European venture capital firm in life sciences, has successfully raised €1.2 billion over the past year, including over €1 billion in the last quarter alone. This fundraising success has increased its total assets under management to more than €4 billion. With significant backing from institutional investors and corporate partners, Sofinnova plans to support 50 to 60 innovative companies in the healthcare and sustainability sectors. The firm boasts a strong international team with expertise across various life sciences fields, further enhancing its impact in the industry.
"All seven of Sofinnova's investment strategies—from incubation to later-stage growth, spanning biotech, medtech, industrial biotech, and digital medicine—have capital to back the next generation of life sciences companies."
"With the new funds, we anticipate supporting 50 to 60 new companies, empowering a new wave of entrepreneurs tackling some of the world's most pressing health and sustainability challenges."
Collection
[
|
...
]